Agilent Technologies announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit for detection of SARS-CoV-2 RNA. The CE-IVD mark is in accordance with the European Union In Vitro Diagnostic Directive and is available for immediate distribution. The single-tube assay provides greater efficiency, higher throughput, less consumable usage, and delivers unambiguous results for confidence in testing outcomes.
Read more about this news here.
